Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Meta Biomed Co., Ltd (059210:KRX), powered by AI.
Meta Biomed Co., Ltd is currently trading at ₩3,815. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Meta Biomed Co., Ltd on Alpha Lenz.
Meta Biomed Co., Ltd's P/E ratio is 9.4.
“Meta Biomed Co., Ltd trades at a P/E of 9.4 (undervalued) with solid ROE of 10.1%. 3Y revenue CAGR of 14.3% highlights clear growth momentum.”
Ask for details →Meta Biomed Co., Ltd is a biomedical and chemical company that specializes in the research, development, and manufacture of medical and dental materials. The company focuses primarily on biopolymers and bio-solutions aimed at improving human health and quality of life. Its product range includes dental materials such as restorative and endodontic items, surgical sutures, and bone graft materials. By leveraging innovative technologies, Meta Biomed strives to address various medical and dental industry needs, providing high-quality and reliable products to healthcare professionals worldwide. As a notable player in the biomedical sector, Meta Biomed Co., Ltd fits into the broader ecosystem of companies contributing to advancements in healthcare and medical treatments. Through its global distribution network, the company extends its reach, impacting the medical and dental care industries significantly.
“Meta Biomed Co., Ltd trades at a P/E of 9.4 (undervalued) with solid ROE of 10.1%. 3Y revenue CAGR of 14.3% highlights clear growth momentum.”
Ask for details →Meta Biomed Co., Ltd (ticker: 059210) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $103.7B.
The current price is ₩3,815 with a P/E ratio of 9.43x and P/B of 0.83x.
ROE is 10.10% and operating margin is 20.81%. Annual revenue is $103.0B.